The future of global cancer standards lies in the integration of personalized medicine, where treatments are tailored to the individual characteristics of each patient. Advances in genomics and biomarker research are paving the way for more precise and effective treatments. Continuous collaboration and innovation will be key in setting and maintaining global standards.
